Mallinckrodt (MNKKQ) News Today $0.02 0.00 (0.00%) As of 07/18/2022 Add Compare Share Share Headlines Stock AnalysisBuy This Stock MNKKQ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Mallinckrodt to file for chapter 11 bankruptcy again and leave $1 ...August 24, 2025 | marketwatch.comS&P Global raises Endo ratings on Mallinckrodt merger completionAugust 1, 2025 | investing.comMallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics LeaderAugust 1, 2025 | prnewswire.comMallinckrodt Receives Necessary Ruling from Irish High Court to Combine with Endo, Inc.July 17, 2025 | prnewswire.comMallinckrodt and Endo Shareholders Approve Combination to Create a Global, Scaled, Diversified Pharmaceuticals LeaderJune 13, 2025 | prnewswire.comMallinckrodt, Endo Announce Planned Leadership Team for Merged CompanyJune 9, 2025 | prnewswire.comMallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals LeaderMarch 13, 2025 | prnewswire.comMallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025March 10, 2025 | prnewswire.comMallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial ResultsFebruary 27, 2025 | prnewswire.comMallinckrodt Completes Divestiture of Therakos® BusinessDecember 2, 2024 | prnewswire.comMallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year GuidanceNovember 5, 2024 | prnewswire.comMallinckrodt plc: Mallinckrodt Reaches Agreement to Sell Therakos Business to CVC for $925 MillionAugust 7, 2024 | finanznachrichten.deDrugmaker Mallinckrodt emerges from bankruptcyNovember 14, 2023 | uk.investing.comMallinckrodt gets approval for restructuring, $1 billion cut to opioid settlementOctober 10, 2023 | investing.comBankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJSeptember 18, 2023 | investing.comDrugmaker Mallinckrodt files for second bankruptcy in USAugust 28, 2023 | investing.comMNK Stock Alert: Mallinckrodt Files for Bankruptcy AgainAugust 23, 2023 | investorplace.comDrugmaker Mallinckrodt considers second bankruptcy filing, other optionsAugust 15, 2023 | investing.comDrugmaker Mallinckrodt in talks with hedge funds to avoid opioid settlements - WSJJuly 27, 2023 | investing.comWhy Is Mallinckrodt (MNK) Stock Down 23% Today?June 5, 2023 | investorplace.comAndrew Left Challenges Mallinckrodt to Do Proper Study of Its Main DrugMay 27, 2023 | thestreet.comMallinckrodt Buys Ikaria in $2.3 Billion Hospital Treatment DealApril 22, 2023 | thestreet.comROSEN, LEADING INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation – MNKApril 2, 2023 | benzinga.comMallinckrodt plc (MNK) Stock Historical Prices & Data - Yahoo FinanceMarch 31, 2023 | finance.yahoo.comEQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation – MNKMarch 22, 2023 | benzinga.comMallinckrodt Plunges on Report It's Considering Filing for BankruptcyMarch 17, 2023 | thestreet.comShort Seller: Mallinckrodt Still Price Gouging on Drug to Treat Seizures in BabiesJanuary 25, 2023 | thestreet.comGlobal SPECT Radiopharmaceuticals Market Research Report 2021-2032 - Yahoo FinanceOctober 19, 2022 | finance.yahoo.comIsoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Yahoo FinanceOctober 18, 2022 | finance.yahoo.comMallinckrodt Ch. 11 Trustee Settles Acthar Royalty Claims - Law360October 13, 2022 | law360.comMallinckrodt Announces Appointment of Susan Silbermann to its Board of DirectorsOctober 11, 2022 | finance.yahoo.comIll. Judge Holds Sanction Bid Over Express Scripts' Doc Dump - Law360October 5, 2022 | law360.com$7M geospatial training campus, from Gateway Global American Youth & Business, planned for vacant North City school, Most Holy Trinity Academy - The Business JournalsSeptember 30, 2022 | bizjournals.comMallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System - PR NewswireSeptember 28, 2022 | prnewswire.comTransCode Therapeutics Appoints MicroRNA Pioneer, Dr. Frank Slack, to its Advisory Board - Yahoo FinanceSeptember 8, 2022 | finance.yahoo.comUS Trustee Objects To OSG Holdings' Ch. 11 Liability Shield - Law360August 26, 2022 | law360.comDrugmaker Endo Files for Bankrupty Over Debt, US Opioid Litigation - BloombergAugust 17, 2022 | bloomberg.comThe Global Hemostats Market to Register Incremental Growth at a CAGR of 5.72% by 2027 | DelveInsight - PR NewswireAugust 16, 2022 | prnewswire.comEndo Creditors Eye Plan for Drugmaker's Sale Through Bankruptcy - BloombergAugust 16, 2022 | bloomberg.comMallinckrodt Noteholders Seek End To Default Payment Appeal - Law360August 9, 2022 | law360.comMALLINCKRODT TO REPORT EARNING - GuruFocus.comAugust 3, 2022 | gurufocus.comAttorneys Get $13M In Fees For Mallinckrodt Securities Deal - Law360August 2, 2022 | law360.com'American Cartel' authors go inside the opioid industry : Shots - Health News - NPRAugust 2, 2022 | npr.orgNThe Global Inhaled Nitric Oxide Market is expected to grow by $ 353.77 mn during 2022-2026, decelerating at a CAGR of 8.6% during the forecast period - Yahoo FinanceAugust 1, 2022 | finance.yahoo.comMinnesota, other states reach tentative $4.25 billion settlement with major opioid manufacturer - Star TribuneJuly 27, 2022 | startribune.comSBoulder County Regional Opioid Council to guide use of opioid settlement funds - Yahoo NewsJuly 20, 2022 | news.yahoo.comMallinckrodt : Bankruptcy or Receivership - Form 8-K/A - Marketscreener.comJuly 3, 2022 | marketscreener.comMMallinckrodt Announces Anticipated Chapter 11 Emergence and Provides Update on Trading of New Ordinary Shares - GuruFocus.comJuly 3, 2022 | gurufocus.comMALLINCKRODT PLC Bankruptcy or Receivership, Financial Statements and Exhibits (form 8-K/A) - Marketscreener.comJuly 3, 2022 | marketscreener.comMIreland Examinership Becoming Critical In Int'l Insolvency - Law360June 30, 2022 | law360.com Get Mallinckrodt News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKKQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MNKKQ Media Mentions By Week MNKKQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKKQ News Sentiment▼0.000.92▲Average Medical News Sentiment MNKKQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKKQ Articles This Week▼00▲MNKKQ Articles Average Week Get the Latest News and Ratings for MNKKQ and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Mallinckrodt and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ACXP News Today TNFA News Today APLM News Today CERO News Today ENSC News Today NKGN News Today CPHI News Today CVSI News Today KTTA News Today PBM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MNKKQ) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mallinckrodt plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mallinckrodt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
